Description:FIELD OF THE INVENTION

[0001] The present invention relates to a wearable health management device developed for continuous monitoring and management of a user’s health, enabling real-time assessment of vital signs, personalized guidance for diet and medication, early detection of critical conditions, and timely alerts for preventive care.

BACKGROUND OF THE INVENTION

[0002] Continuous monitoring of vital health parameters is critical for maintaining overall well-being, early detection of health anomalies, and effective disease management. Real-time data on heart rate, blood pressure, oxygen saturation, and other metrics can help individuals and healthcare providers make timely interventions, reducing risks of complications. Health management faces several challenges that hinder effective monitoring and treatment. Many individuals struggle with irregular tracking of vital signs, delayed detection of critical conditions, and lack of personalized guidance for diet, medication, or lifestyle. Chronic diseases such as diabetes and heart conditions require constant monitoring, but traditional methods are time-consuming, manual, and prone to human error. Patients may miss medication doses, fail to follow nutritional plans, or be unaware of sudden health deteriorations. Limited communication with healthcare provider’s further delays interventions.

[0003] Traditionally, vital parameters are monitored through periodic checkups, manual measurements, and hospital-based equipment. Devices like sphygmomanometers, pulse oximeters, and electrocardiograms are used to record heart rate, blood pressure, and oxygen levels at specific times. These methods provide snapshots rather than continuous monitoring and require professional supervision or frequent self-checks. While effective for clinical diagnosis, they are inconvenient for everyday health tracking. Patients with chronic conditions must repeatedly visit healthcare facilities or manually log their health data, limiting real-time awareness and timely response to sudden changes in their health status.

[0004] US9357921B2 discloses a health monitoring device, with an attached strap, capable of sensing characteristics of the individual. These characteristics may include voice level and tone, movements, blood pressure, temperature, etc. The device allows individuals to constantly monitor their health without having to physically visit a doctor or other health care professional. Wireless communication, for instance with an Internet Protocol Television (IPTV) set-top box, allows measurements to be made and evaluated by a ‘computerized’ healthcare service provider. For a more accurate evaluation, measurements are sent over the INTERNET to a service. The device communicates with services in order to diagnose the individual based upon the characteristics.

[0005] WO2022049592A1 discloses an interactive wearable tranquillity health monitoring device. Wearable device is smart band in the form of smart watch for stress detection which assist a person for meditation notified by an alarm signal whenever the user feels stressed. The smart band of the present invention comprises comprising a screen (1) as user interface, a GPS unit, battery, vibration motor, microprocessor, an accelerometer, SOS button (2), Bluetooth, speakers and a case (3) said device embedded with minimum six meditations, said device provides core workflow with stress alert and reminder.

[0006] Conventionally, many devices have been developed to facilitate health monitoring, however these existing devices mentioned in prior arts have limitations pertaining to provide continuous, reliable monitoring for critical health parameters and fail to provide actionable insights and unable alert users or caregivers in case of abnormal readings. Additionally, these existing devices also fail in detecting changes in blood sugar levels and providing timely alerts to prevent critical health conditions.

[0007] In order to overcome the aforementioned drawbacks, there exists a need in the art to develop a device that requires to be capable of executing continuous, real-time monitoring with high accuracy, automating data analysis with producing instant alerts, and seamlessly tracking vital signs, identifying deviations, and communicating critical information to healthcare providers or caregivers. Additionally, the developed device also needs to be capable of providing proactive health management, improving patient outcomes and supporting independent living, especially for individuals with chronic conditions or high-risk health profiles.

OBJECTS OF THE INVENTION

[0008] An object of the present invention is to develop a device that is capable of continuously monitoring a user’s vital health parameters and provide accurate real-time health data.

[0009] Another object of the present invention is to develop a device that is capable of detecting changes in blood sugar levels and provide timely alerts to prevent critical health conditions.

[0010] Another object of the present invention is to develop a device that is capable of assisting in managing diet and nutrition by analyzing food intake and offering personalized recommendations.

[0011] Another object of the present invention is to develop a device that is capable of automatically administer medications and insulin in precise doses based on the user’s health needs.

[0012] Another object of the present invention is to develop a device that is capable of recognizing and responding to critical respiratory or health events, enabling prompt intervention.

[0013] Yet another object of the present invention is to develop a device that is capable of facilitating communication with caregivers or healthcare providers in case of abnormal health conditions.

[0014] The foregoing and other objects, features, and advantages of the present invention will become readily apparent upon further review of the following detailed description of the preferred embodiment as illustrated in the accompanying drawings.

SUMMARY OF THE INVENTION

[0015] The present invention relates to a wearable health management device developed for continuously tracking a user’s health, providing real-time evaluation of vital signs, offering personalized diet and medication guidance, identifying critical health changes early, and delivering timely alerts to support preventive care.

[0016] According to an aspect of the present invention, a wearable health management device, comprising a wearable body adapted to be worn by a user over wrist portion, a rotatable AI (artificial intelligence) camera installed on a front portion of the body and paired with an integrated LiDAR (Light detection and ranging) sensor for capturing images and spatial data of surroundings and user, a thermal sensor arranged on the body for detecting user presence and measuring respiration rate by sensing temperature fluctuations around the nostrils or face, a processor integrated with the camera and thermal sensor, configured to perform facial recognition to identify the user and utilize machine learning protocols to generate a respiratory fingerprint for two-factor authentication and health monitoring, a dual-layer vital monitoring module integrated within the body for continuous and accurate measurement of blood sugar levels.

[0017] According to another aspect of the present invention, the device further includes a medicine dispensing and insulin-injecting arrangement integrated with the body to store and dispense medicines and deliver insulin injections automatically, a touchscreen display is positioned on the front of the body, providing an interactive user interface displaying health metrics, alerts, and real-time recommendations for diet and medication, a 3D (three-dimension) holographic projector is integrated within the body for displaying customized physical exercise routines and warnings based on daily vital signs and blood sugar levels, a plurality of storage units are provided with the body, configured to store different types of medicines for timely and selective dispensing based on the user’s real-time health parameters.

[0018] While the invention has been described and shown with particular reference to the preferred embodiment, it will be apparent that variations might be possible that would fall within the scope of the present invention.

BRIEF DESCRIPTION OF THE DRAWINGS

[0019] These and other features, aspects, and advantages of the present invention will become better understood with regard to the following description, appended claims, and accompanying drawings where:
Figure 1 illustrates an isometric view of a wearable health management device.

DETAILED DESCRIPTION OF THE INVENTION

[0020] The following description includes the preferred best mode of one embodiment of the present invention. It will be clear from this description of the invention that the invention is not limited to these illustrated embodiments but that the invention also includes a variety of modifications and embodiments thereto. Therefore, the present description should be seen as illustrative and not limiting. While the invention is susceptible to various modifications and alternative constructions, it should be understood, that there is no intention to limit the invention to the specific form disclosed, but, on the contrary, the invention is to cover all modifications, alternative constructions, and equivalents falling within the spirit and scope of the invention as defined in the claims.

[0021] In any embodiment described herein, the open-ended terms "comprising," "comprises,” and the like (which are synonymous with "including," "having” and "characterized by") may be replaced by the respective partially closed phrases "consisting essentially of," consists essentially of," and the like or the respective closed phrases "consisting of," "consists of, the like.

[0022] As used herein, the singular forms “a,” “an,” and “the” designate both the singular and the plural, unless expressly stated to designate the singular only.

[0023] The present invention relates to a wearable health management device developed for ongoing health monitoring, allowing real-time observation of vital signs, personalized recommendations for diet and medication, early detection of potential health issues, and prompt alerts to help maintain overall well-being.

[0024] Referring to Figure 1, an isometric view of a wearable health management device is illustrated, comprising of a wearable body 101 adapted to be worn by a user over wrist portion, a rotatable AI (artificial intelligence) camera 102 installed on a front portion of the body 101, a thermal sensor 103 arranged on the body 101, a dual-layer vital monitoring module 104 integrated within the body 101, a touchscreen display 105 positioned on the front of the body 101.

[0025] Figure 1 further illustrates a medicine dispensing and insulin-injecting arrangement integrated with the body 101, the medicine dispensing and insulin-injecting arrangement includes a dedicated micro-sized insulin chamber 106 provided with the body 101, a spring-loaded, retractable auto-injector needle 107 connected to the insulin chamber 106, a hollow conduit 108 integrated between the chamber 106 and the needle 107, a 3D (three-dimension) holographic projector 109 integrated within the body 101, a plurality of storage units 110 provided with the body 101, and a haptic feedback unit 111 integrated with the body 101.

[0026] The device disclosed herein comprises of a wearable body 101 adapted to be worn by a user over the wrist portion. The body 101 refers to a structural component designed and configured to encircle, secure, and remain positioned around the user’s wrist in a stable and ergonomic manner. The wearable body 101 is constructed to conform to the anatomical contour of the wrist and incorporate fastening or adjustment means to ensure a secure yet comfortable fit. The ergonomic structure allows the wearable to remain functional under various conditions, distributing weight evenly and minimizing user discomfort.

[0027] A rotatable AI (artificial intelligence) camera 102 mounted on a front portion of the body 101 and paired with an integrated LiDAR (Light detection and ranging) sensor for capturing images and spatial data of surroundings and user. The camera 102 dynamically adjusting its orientation for enabling 360-degree or multi-axis field-of-view coverage. The camera 102 continuously captures real-time visual data of the environment and user, which is processed by integrated AI protocols to identify, classify, and track objects, gestures, or movements. The rotational capability ensures uninterrupted monitoring and eliminates blind spots. The camera 102 autonomously optimizes focus, exposure, and angle based on environmental conditions and user interaction.

[0028] The captured data is securely transmitted to an integrated processor for further analytical or operational functions. The LiDAR sensor functions by emitting rapid pulses of laser light toward surrounding objects and measuring the time taken for each pulse to return after reflection. This time-of-flight data is converted into precise distance measurements, generating a high-resolution, three-dimensional spatial map of the environment. The sensor continuously scans the surroundings in coordination with the rotatable camera 102, enabling accurate detection of object contours, dimensions, and positions. The collected spatial data is processed to determine proximity, depth, and movement dynamics, facilitating advanced environmental perception.

[0029] A thermal sensor 103 arranged on the body 101 is configured to detect user presence and monitor respiration rate by sensing minute temperature variations in the surrounding air, particularly near the nostrils or facial region. Upon user proximity, the sensor 103 identifies the thermal signature emitted by the body 101, thereby confirming presence. Furthermore, as the user inhales and exhales, cyclic temperature changes occur, which the sensor 103 captures with high sensitivity. These measured fluctuations are processed to determine respiratory patterns and rates. The thermal sensor 103 herein operates by detecting infrared radiation emitted due to temperature differences.

[0030] When positioned near the nostrils or face, inhalation draws cooler ambient air inward, reducing the sensed temperature, while exhalation releases warmer air, increasing it. This periodic variation produces a temperature waveform corresponding to the respiratory cycle. The sensor 103 converts these thermal signals into electrical outputs, which are processed by the processor to calculate respiration rate and confirm presence. Consistent detection of such temperature cycles indicates active breathing, while absence of fluctuations signals non-presence or cessation, enabling responsive system functionalities. The processor, integrated with the camera 102 and thermal sensor 103, executes real-time data acquisition and processing operations.

[0031] The processor captures facial features and thermal signatures, applies encrypted biometric protocols to authenticate user identity, and simultaneously initiates respiratory signal analysis for generating a unique respiratory fingerprint. This fingerprint serves as a secondary authentication layer and is continuously monitored for deviations indicating health anomalies. The processor further adapts data routing, pre-processing, and secure transmission to machine learning modules. The processor ensuring synchronized operation of all subsystems, maintaining compliance with privacy standards, and enabling seamless two-factor authentication and health surveillance functions in real time.

[0032] The machine learning protocols herein process multi-dimensional data streams, including visual, thermal, and historical metabolic data, through predictive and classification models. The protocols estimate food composition and portion size by analyzing captured images against trained datasets, correlating recognized food items with nutritional databases. The historical glucose response patterns are integrated to personalize dietary recommendations, dynamically adjusting based on individual metabolic trends. Simultaneously, respiratory signal patterns are processed to refine the user’s biometric fingerprint, enhancing authentication reliability.

[0033] A dual-layer vital monitoring module 104, integrated within the body 101, operates by sequentially acquiring and verifying blood glucose data through two integrated sensing layers. The dual-layer vital monitoring module 104 includes a microfluidic sensor arranged on a bottom surface of the body 101, and an amplitude-modulated ultrasound and Near-Infrared (NIR) spectroscopy sensor integrated within the body 101. Initially, the microfluidic sensor performs a primary estimation of blood glucose concentration. This data is then transmitted to the secondary layer, where amplitude-modulated ultrasound and Near-Infrared (NIR) spectroscopy sensors engage to authenticate the initial reading by analyzing molecular vibrational signatures and optical absorption characteristics.

[0034] The dual-layer configuration ensures redundant verification, enhances measurement reliability, and enables continuous, real-time monitoring of blood glucose with high precision and minimal invasive interaction. The microfluidic sensor herein functions by directing a controlled volume of interstitial fluid or blood sample through micro-channels embedded within the sensor matrix. As the fluid traverses these channels, embedded biochemical or electrochemical detection elements react with glucose molecules, generating measurable electrical signals proportional to glucose concentration. These signals are then processed to estimate the initial blood sugar level.

[0035] The sensor’s precise fluid handling enables rapid sampling and real-time measurement while minimizing sample volume requirements. The module 104 initiates the dual-layer analysis process by delivering the preliminary glucose data for subsequent verification. The amplitude-modulated ultrasound and NIR spectroscopy sensor mentioned herein verifies glucose levels. The ultrasound waves, modulated in amplitude, propagate through the tissue, and variations in acoustic impedance induced by glucose concentration are measured.

[0036] Simultaneously, NIR light is directed into the tissue, and its absorption and scattering patterns, influenced by glucose’s molecular vibrations and optical properties, are analyzed. The combined data from these modalities is cross-referenced with the microfluidic sensor’s estimate, ensuring high-fidelity verification. This dual-method approach enhances accuracy by compensating for interferences and enables continuous, non-invasive confirmation of blood glucose concentration within the integrated monitoring module 104.

[0037] A touchscreen display 105 is positioned on the front of the body 101 constituting an interactive interface through which the end-user access, review, and respond to health-related data, including but not limited to biometric metrics, clinical alerts, and real-time guidance concerning dietary and pharmacological regimens. This interface is designed to facilitate informed decision-making by the user while ensuring clarity and accessibility of medical information. The touchscreen display 105 functions by detecting the presence and location of a user’s touch within the display 105 area.

[0038] In capacitive display 105, a conductive layer senses changes in the electrostatic field when a finger contacts the screen, converting these changes into electrical signals. In resistive display 105, two flexible layers separated by a gap register pressure points when pressed together. The processor interprets these signals and maps them to corresponding coordinates on the display 105. The processor then triggers the appropriate response, enabling real-time interaction with the interface. The display 105 updates dynamically, providing visual feedback of selections, notifications, or changes in health metrics.

[0039] A medicine dispensing and insulin-injecting arrangement integrated with the body 101 for autonomously storing, regulating, and delivering both insulin and oral medications. Insulin is maintained in a micro-insulin chamber 106 provided with the body 101 at optimal temperature and is administered through a spring-loaded auto-injector needle 107 connected to the insulin chamber 106, while oral medicines are delivered through a dedicated conduit 108 integrated between the chamber 106 and the needle 107. The arrangement communicates with the processor to initiate medicine release precisely. Upon activation, a pneumatic micro-plunger forces insulin through the needle 107, while the conduit 108 ensures controlled oral drug delivery.

[0040] The dedicated micro-sized insulin chamber 106 herein functions as a reservoir for insulin, maintaining sufficient supply for scheduled or emergency dosing. The chamber 106 interfaces with the thermoelectric cooling module to regulate temperature and preserve insulin stability. The chamber 106 communicates with the pneumatic micro-plunger and auto-injector needle 107 to release insulin accurately. Upon receiving a delivery signal, the chamber 106 dispenses insulin into the conduit 108 leading to the injection site. The chamber 106 provides a stable, controlled environment, preventing degradation and ensuring consistent therapeutic efficacy.

[0041] A thermoelectric cooling module integrated with the chamber 106 actively regulates the temperature of the insulin chamber 106, maintaining insulin within an optimal therapeutic range. The module functions by transferring heat away from the chamber 106 via the Peltier effect, powered by the device’s internal energy source. When the insulin temperature exceeds or drops below pre-set thresholds, the module activates to either cool or maintain equilibrium. This ensures insulin remains chemically stable and effective prior to delivery.

[0042] The module continuously monitors chamber 106 temperature, providing feedback to the processor to modulate cooling. The precise thermal control of the module prevents insulin degradation. The spring-loaded, retractable auto-injector needle 107 herein is designed to deliver insulin safely and precisely into the user’s body 101. Upon activation, the spring propels the needle 107 through the skin rapidly, minimizing discomfort and ensuring proper subcutaneous placement. The needle 107 receives a controlled dose of insulin, while an integrated flow rate sensor confirms completion.

[0043] The retractable design of the needle 107 ensures hygienic operation and repeated usability. The spring force is calibrated to accommodate skin resistance while ensuring full insulin delivery, providing consistent, automated injection performance. The integrated flow rate sensor herein monitors the volume and velocity of insulin delivered through the auto-injector needle 107 in real-time. The sensor detects deviations from dosage parameters and provides feedback to the processor to adjust the pneumatic micro-plunger or halt delivery if anomalies occur. The sensor ensures precise therapeutic delivery by continuously measuring flow continuity, detecting blockages, and validating complete dosage transfer.

[0044] The pneumatic micro-plunger mentioned herein functions to force insulin from the micro-sized chamber 106 through the auto-injector needle 107 in a controlled manner. When activated, compressed air or fluid pressure drives the plunger linearly, pushing the precise volume of insulin through the conduit 108 for subcutaneous injection. The plunger’s motion is coordinated with the flow rate sensor to ensure accurate delivery. The pneumatic operation of the plunger allows smooth, adjustable force without mechanical strain on the chamber 106 or needle 107. The hollow conduit 108 mentioned above provides a direct, sterile pathway between the insulin chamber 106 and the auto-injector needle 107, enabling precise delivery of insulin. The conduit 108 also serves as a channel for oral medicines, guiding measured doses to the user at scheduled times.

[0045] The conduit’s dimensions and material ensure minimal resistance and prevent contamination or leakage. During operation, the pneumatic micro-plunger propels the insulin through the conduit 108, while the flow rate sensor monitors fluid passage to confirm accurate delivery. The conduit 108 integrates seamlessly with the retractable needle 107 and chamber 106, supporting automated, controlled, and timed medicine administration, ensuring both subcutaneous injections and oral dosing are precise and reliable. A communication interface directly integrated with the processor, configured to transmit emergency alerts to pre-designated caregivers upon detection of abnormal glucose levels or other critical health anomalies.

[0046] The interface ensures real-time monitoring and prompt notification, thereby facilitating timely medical intervention and mitigating potential health risks. The communication interface receives processed signals from the processor regarding patient health metrics. Upon detecting threshold breaches, the interface converts these digital signals into secure transmission protocols, such as SMS, email, or mobile app notifications. The interface verifies recipient credentials, encrypts data for privacy, and transmits alerts to registered caregivers. The interface logs each transmission event, confirming delivery status and allowing system audits.

[0047] A three-dimensional (“3D”) holographic projector 109 integrated within the body 101 to provide visualized exercise regimens suitable to the individual user. The processor monitors physiological parameters, including vital signs and blood glucose levels, and delivers corresponding warnings when thresholds are exceeded. The 3D holographic projector 109 operates by emitting coherent laser beams from embedded light sources. These beams are split and directed through a series of micro-electromechanical mirrors, generating interference patterns on a photorefractive medium.

[0048] The interference patterns reconstruct light waves to form volumetric images perceptible to the human eye without external displays. The processor continuously adjusts beam intensity and phase in real time, creating dynamic, moving projections. Data inputs from sensors guide the content displayed, enabling interactive visualization. The holographic volume is refreshed at high frequency, allowing lifelike rendering of exercise routines, alerts, and biometric feedback within the user’s immediate spatial environment.

[0049] A plurality of storage units 110 integrated within the body 101, each configured to securely store distinct categories of medicinal substances. The storage units 110 are operatively connected to the processor that enables selective dispensing of the stored medicines in accordance with the user’s real-time health parameters. The plurality of storage units 110 ensures segregation of medications to prevent cross-contamination and allows for targeted administration. Dispensation occurs automatically or upon authorized initiation, thereby facilitating timely, precise, and condition-specific therapeutic interventions.

[0050] Each storage unit functions as an individual compartment, holding a specific type of medicine. The processor evaluates the health data against predefined thresholds and determines the precise medicine required. Upon authorization, actuators trigger the selected storage unit to release the appropriate dosage through a dispensing operation. This coordinated operation ensures timely, selective, and condition-specific delivery of multiple medications, while maintaining security and accuracy of stored pharmaceutical substances.

[0051] The processor is further adapted and configured to continuously monitor the user’s respiratory parameters, analyze the collected data in real-time, and identify critical deviations indicative of severe or life-threatening respiratory health events. Upon detection of such events, the processor autonomously generates and transmits timely alerts to the user, thereby enabling immediate emergency intervention. The processor ensures rapid communication of potential health crises, facilitating prompt medical response and mitigating risk of complications.

[0052] A haptic feedback unit 111 integrated with the body 101 to deliver tactile stimuli to the user in accordance with schedules and real-time physiological data. The feedback unit 111 is operatively coupled with the monitoring module that tracks glucose levels and medication timing, thereby generating discrete haptic signals to alert the user of impending or overdue insulin administration or medication intake. The haptic feedback unit 111 receives input signals from an external or implanted monitoring system, which provides real-time data on glucose levels and scheduled medication events. Upon detection of a threshold event or scheduled alert, the haptic feedback unit 111 converts electrical signals into mechanical vibrations via actuators embedded in contact points on the body 101. The intensity, duration, and pattern of vibrations are modulated according to the urgency and type of alert.

[0053] Moreover, a battery is associated with the device to supply power to electrically powered components which are employed herein. The battery is comprised of a pair of electrodes known as a cathode and an anode. A voltage is generated between the anode and cathode via oxidation/reduction and thus produces the electrical energy to provide to the device.

[0054] The present invention works best in following manner, where the body 101 as disclosed in the invention is adapted to be worn over the wrist portion of the user. The body 101 houses the processor configured as the central microcontroller. The rotatable AI camera 102 is installed on the front portion of the body 101 and is paired with the integrated LiDAR sensor to capture high-resolution images and spatial data of the surroundings and the user. The processor utilizes machine learning protocols to analyze the captured images, perform facial recognition for user identification, and generate a unique respiratory fingerprint for two-factor authentication and health monitoring. The AI camera 102 and LiDAR sensor further capture and analyze images of meals, enabling the processor to estimate food composition, portion size, and provide personalized dietary recommendations based on historical glucose response data. The thermal sensor 103 arranged on the body 101 detects user presence and measures respiration rate by sensing temperature fluctuations around the nostrils or face. The processor continuously interprets thermal data to detect critical respiratory health events and generate timely alerts for emergency intervention. The dual-layer vital monitoring module 104 integrated within the body 101 provides continuous and accurate measurement of blood sugar levels.

[0055] In continuation, the microfluidic sensor on the bottom surface of the body 101 estimates initial blood sugar levels, while the amplitude-modulated ultrasound and near-infrared spectroscopy sensor verifies the measurement through molecular vibration and optical property analysis, ensuring precision. The medicine dispensing and insulin-injecting arrangement integrated with the body 101 stores and delivers medicines and insulin automatically. The dedicated micro-sized insulin chamber 106 is maintained at optimal temperature by the thermoelectric cooling module. The spring-loaded retractable auto-injector needle 107, coupled with the pneumatic micro-plunger, delivers precise insulin doses, and the hollow conduit 108 ensures accurate delivery of oral medicines at scheduled times. The touchscreen display 105 provides an interactive interface presenting real-time health metrics, alerts, and recommendations. The 3D holographic projector 109 displays customized exercise routines and health warnings. The haptic feedback unit 111 provide reminders for medication and insulin dosing. The communication interface sends emergency notifications to designated caregivers when critical health events are detected.

[0056] Although the field of the invention has been described herein with limited reference to specific embodiments, this description is not meant to be construed in a limiting sense. Various modifications of the disclosed embodiments, as well as alternate embodiments of the invention, will become apparent to persons skilled in the art upon reference to the description of the invention. , Claims:1) A wearable health management device, comprising:
i) a wearable body 101 adapted to be worn by a user over wrist portion;
ii) a rotatable AI (artificial intelligence) camera 102 installed on a front portion of the body 101 and paired with an integrated LiDAR (Light detection and ranging) sensor for capturing images and spatial data of surroundings and user;
iii) a thermal sensor 103 arranged on the body 101 for detecting user presence and measuring respiration rate by sensing temperature fluctuations around the nostrils or face;
iv) a processor integrated with the camera 102 and thermal sensor 103, configured to perform facial recognition to identify the user and utilize machine learning protocols to generate a respiratory fingerprint for two-factor authentication and health monitoring;
v) a dual-layer vital monitoring module 104 integrated within the body 101 for continuous and accurate measurement of blood sugar levels; and
vi) a medicine dispensing and insulin-injecting arrangement integrated with the body 101 to store and dispense medicines and deliver insulin injections automatically.

2) The device as claimed in claim 1, wherein a touchscreen display 105 is positioned on the front of the body 101, providing an interactive user interface displaying health metrics, alerts, and real-time recommendations for diet and medication.

3) The device as claimed in claim 1, wherein the dual-layer vital monitoring module 104, includes:
a) a microfluidic sensor arranged on a bottom surface of the body 101 to estimate initial blood sugar levels, and
b) an amplitude-modulated ultrasound and Near-Infrared (NIR) spectroscopy sensor integrated within the body 101 to verify the initial blood sugar estimate through molecular vibration and optical property analysis.

4) The device as claimed in claim 1, wherein the medicine dispensing and insulin-injecting arrangement, includes:
a) a dedicated micro-sized insulin chamber 106 provided with the body 101, maintained at an optimal temperature by a thermoelectric cooling module,
b) a spring-loaded, retractable auto-injector needle 107 connected to the insulin chamber 106, with an integrated flow rate sensor to ensure precise insulin dosage delivery,
c) a pneumatic micro-plunger configured to push insulin through the auto-injector needle 107 into the user’s body, and
d) a hollow conduit 108 integrated between the chamber 106 and the needle 107 to deliver precise quantities of oral medicines at scheduled times.

5) The device as claimed in claim 1, wherein a communication interface is interlinked with the processor to send emergency notifications to designated caregivers when abnormal glucose levels or critical health events are detected.

6) The device as claimed in claim 1, wherein the AI camera 102 and LiDAR sensor is configured to capture and analyze images and dimensions of meals, and machine learning protocols integrated with the processor estimate food composition and portion size, and provide personalized dietary recommendations based on historical user glucose responses.

7) The device as claimed in claim 1, wherein a 3D (three-dimension) holographic projector 109 is integrated within the body 101 for displaying customized physical exercise routines and warnings based on daily vital signs and blood sugar levels.

8) The device as claimed in claim 1, wherein a plurality of storage units 110 are provided with the body 101, configured to store different types of medicines for timely and selective dispensing based on the user’s real-time health parameters.

9) The device as claimed in claim 1, wherein the processor is further configured to detect critical respiratory health events, and provide timely alerts for emergency intervention.

10) The device as claimed in claim 1, wherein a haptic feedback unit 111 is integrated with the body 101 to provide haptic feedback reminders for medication and insulin doses based on user schedules and real-time glucose measurements.